Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26 (2) , 211-215
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
This publication has 14 references indexed in Scilit:
- Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016Journal of Infection and Chemotherapy, 2018
- The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011–2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age groupInfection, 2017
- Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2017
- Japanese antimicrobial consumption surveillance: First report on oral and parenteral antimicrobial consumption in Japan (2009–2013)Journal of Global Antimicrobial Resistance, 2016
- Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problemTherapeutic Advances in Drug Safety, 2014
- Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adultsCurrent Medical Research and Opinion, 2006
- Cefdinir versus cephalexin for the treatment of skin and skin-structure infectionsClinical Therapeutics, 1998
- Risk factors for methicillin-resistant staphylococcus aureus (MRSA) infection in a Japanese geriatric hospitalPublic Health, 1997
- Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study GroupAntimicrobial Agents and Chemotherapy, 1997
- Pharmacokinetics of Cefaclor and Cephalexin: Dosage Nomograms for Impaired Renal FunctionAntimicrobial Agents and Chemotherapy, 1978